BRIEF

on CEGEDIM (EPA:CGM)

Strategic partnership between Cegedim and PHAST to improve the traceability of medical devices

Stock price chart of CEGEDIM (EPA:CGM) showing fluctuations.

Cegedim Business Services and PHAST announce a partnership aimed at strengthening the traceability of implantable medical devices (IMDs) in hospitals. This partnership is part of the regulatory challenges related to the management of IMDs in healthcare institutions. Sedistock, Cegedim's solution, will use the CIOdm interoperability catalog to ensure better interoperability between applications in the IMD circuit.

This partnership promises to streamline information exchanges, thus meeting the growing requirements in terms of traceability. Care teams will benefit from time savings and data optimization. Sedistock and CIOdm customers will see their traceability processes simplified. The solution also helps to monitor reimbursement indications for medical devices.

The two companies will present their collaboration at the Euro-Pharmat trade fair in Lille.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CEGEDIM news